Miraca Life Sciences Research Institute, Irving, Texas 75039, USA.
J Clin Pathol. 2013 Feb;66(2):136-9. doi: 10.1136/jclinpath-2012-201102. Epub 2012 Dec 4.
This study was designed to establish the relative prevalence of intestinal-type and signet-ring carcinoma in gastric biopsy specimens from ambulatory patients, to determine the percentage of signet-ring carcinomas that could be expected based on the available clinical and endoscopic information, and to estimate the likelihood of missing a tumour.
We extracted data of all patients with a diagnosis of primary gastric carcinoma from a national pathology database. We then reviewed clinical information and original slides, classified tumours as intestinal or signet-ring-type, and categorised the latter as 'unexpected' (no alarming symptoms, no mention of suspicious lesions) or 'expected' (clinical or endoscopic information suggestive of tumour). Unexpected signet-ring carcinomas were categorised as 'obvious' or 'challenging' (rare signet-ring cells; immunohistochemical stains used to confirm the nature of the infiltrates).
There were 310 109 patients with gastric biopsies; 615 patients had primary gastric carcinoma (359 intestinal and 256 signet-ring-type). Gastric cancer was more common in men (OR 2.54; 95% CI 2.05 to 3.14; p<.0001) for intestinal-type and (OR 1.90; 95% CI 1.48 to 2.42; p<0.0001) for signet-ring cell type). Intestinal-type carcinoma occurred in older patients than signet-ring-type (median age 74 vs 65 years, p<0.001). There were 196 expected and 60 unexpected signet-ring carcinomas; 47 of the 60 unexpected cases were histopathologically obvious. Thus, only 13 signet-ring carcinomas (1 in 25 000 gastric biopsy sets) were truly unexpected.
Signet-ring carcinoma is a rare finding in gastric biopsy specimens from ambulatory patients; routine due diligence and the clinical/endoscopic information provided are usually adequate to raise pathologists' index of suspicion.
本研究旨在确定门诊患者胃活检标本中肠型和印戒细胞癌的相对患病率,确定基于现有临床和内镜信息可预期的印戒细胞癌比例,并估计漏诊肿瘤的可能性。
我们从一个全国性的病理数据库中提取了所有原发性胃癌患者的数据。然后,我们回顾了临床信息和原始切片,将肿瘤分类为肠型或印戒细胞型,并将后者分为“意外”(无报警症状,无可疑病变提及)或“预期”(提示肿瘤的临床或内镜信息)。意外的印戒细胞癌被分为“明显”或“具有挑战性”(罕见的印戒细胞;使用免疫组化染色来确认浸润的性质)。
有 310 109 例胃活检患者;615 例患者患有原发性胃癌(359 例肠型和 256 例印戒细胞型)。男性患胃癌的风险高于女性(肠型的 OR 为 2.54;95%CI 为 2.05 至 3.14;p<.0001)和印戒细胞型(OR 为 1.90;95%CI 为 1.48 至 2.42;p<.0001)。肠型癌发生在比印戒细胞型更年长的患者中(中位年龄 74 岁 vs 65 岁,p<.001)。有 196 例预期的和 60 例意外的印戒细胞癌;60 例意外病例中有 47 例组织病理学上明显。因此,只有 13 例印戒细胞癌(25000 例胃活检中 1 例)是真正意外的。
印戒细胞癌在门诊患者的胃活检标本中是一种罕见的发现;常规的尽职调查和提供的临床/内镜信息通常足以提高病理学家的怀疑指数。